| abstract |
The present invention provides a phosphorus-containing compound characterized by being a compound represented by the following structure: n n n n n n n n n n n n the compound is a novel immune cell migration inhibitor. The compound has good hydrophilicity and can be developed into eye drops. The compound has a strong inhibitory ability to immune cell migration and can relieve the symptoms of most dry-eye patients. |